Pathway-centric structure-based multi-target compound screening for anti-virulence drug repurposing

L Xie, L Xie - International Journal of Molecular Sciences, 2019 - mdpi.com
The emergence of superbugs that are resistant to last-resort antibiotics poses a serious
threat to human health, and we are in a “race against time to develop new antibiotics.” New …

hCB2 ligand-interaction landscape: cysteine residues critical to biarylpyrazole antagonist binding motif and receptor modulation

RW Mercier, Y Pei, L Pandarinathan, DR Janero… - Chemistry & biology, 2010 - cell.com
The human cannabinoid 2 GPCR (hCB2) is a prime therapeutic target. To define potential
cysteine-related binding motifs critical to hCB2-ligand interaction, a library of hCB2 cysteine …

Recent advances in the development of pyrazole derivatives as anticancer agents

Y Zhang, C Wu, N Zhang, R Fan, Y Ye, J Xu - International Journal of …, 2023 - mdpi.com
Pyrazole derivatives, as a class of heterocyclic compounds, possess unique chemical
structures that confer them with a broad spectrum of pharmacological activities. They have …

Pyridine: the scaffolds with significant clinical diversity

S De, AK SK, SK Shah, S Kazi, N Sarkar, S Banerjee… - Rsc Advances, 2022 - pubs.rsc.org
The nitrogen-bearing heterocycle pyridine in its several analogous forms occupies an
important position as a precious source of clinically useful agents in the field of medicinal …

Synthesis and vectorial functionalisation of pyrazolo [3, 4-c] pyridines

EV Bedwell, F da Silva Emery, GC Clososki, PG Steel - RSC advances, 2023 - pubs.rsc.org
Heterocycles are a cornerstone of fragment-based drug discovery (FBDD) due to their
prevalence in biologically active compounds. However, novel heterocyclic fragments are …

A comprehensive review on recent developments in the field of biological applications of potent pyrazolines derived from chalcone precursors

VV Salian, B Narayana, BK Sarojini… - Letters in Drug Design …, 2018 - ingentaconnect.com
Background: Pyrazoline scaffold is a key structural motif found among pharmaceutically
active molecules including synthetic and natural products. The molecules with pyrazoline …

Enhancing drug efficacy and therapeutic index through cheminformatics-based selection of small molecule binary weapons that improve transporter-mediated …

JM Grixti, S O'Hagan, PJ Day, DB Kell - Frontiers in Pharmacology, 2017 - frontiersin.org
The transport of drug molecules is mainly determined by the distribution of influx and efflux
transporters for which they are substrates. To enable tissue targeting, we sought to develop …

Crystal structures of ABL-related gene (ABL2) in complex with imatinib, tozasertib (VX-680), and a type I inhibitor of the triazole carbothioamide class

E Salah, E Ugochukwu, AJ Barr… - Journal of medicinal …, 2011 - ACS Publications
ABL2 (also known as ARG (ABL related gene)) is closely related to the well-studied Abelson
kinase cABL. ABL2 is involved in human neoplastic diseases and is deregulated in solid …

Exploring the untapped pharmacological potential of imidazopyridazines

MS Malik, HF Alshareef, KA Alfaidi, H Ather… - RSC …, 2024 - pubs.rsc.org
Imidazopyridazines are fused heterocycles, like purines, with a pyridazine ring replacing the
pyrimidine ring in purines. Imidazopyridazines have been primarily studied for their kinase …

Direct and sequential bioactivation of pemigatinib to reactive iminium ion intermediates culminates in mechanism-based inactivation of cytochrome P450 3A

LWT Tang, W Wei, RK Verma, SK Koh, L Zhou… - Drug Metabolism and …, 2022 - ASPET
We recently established the mechanism-based inactivation (MBI) of cytochrome P450 3A
(CYP3A) by the fibroblast growth factor receptor (FGFR) inhibitors erdafitinib and infigratinib …